Compare GNLN & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLN | SBFM |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | 50 |
| Industry | Durable Goods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 2.2M |
| IPO Year | 2019 | 2008 |
| Metric | GNLN | SBFM |
|---|---|---|
| Price | $1.72 | $3.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.5K | ★ 10.3M |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.57 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $13,275,000.00 | ★ $36,305,891.00 |
| Revenue This Year | N/A | $1.23 |
| Revenue Next Year | N/A | $22.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.11 |
| 52 Week Low | $1.51 | $0.13 |
| 52 Week High | $139.60 | $18.50 |
| Indicator | GNLN | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 32.39 | 87.31 |
| Support Level | $1.51 | $1.06 |
| Resistance Level | $2.14 | $13.50 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | -0.06 | 0.39 |
| Stochastic Oscillator | 0.00 | 98.64 |
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). It serves specialty retailers, smoke shops, head shops, convenience stores, and consumers. Geographically, it operates in United States, Canada, and Europe. It derives majority revenue from the United States. Its two operating segments are: Wholesale and Distribution, which includes legacy e-commerce and drop-ship operations; and Digital Assets, which includes digital asset treasury activities including acquisition, staking and validator participation related to BERA.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.